Navigation Links
New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
Date:1/23/2008

Experts Urge Integration of Adult Vaccines into Routine Care to Save Lives,

Reduce Needless Illness

WASHINGTON, Jan. 23 /PRNewswire-USNewswire/ -- New data released today by the Centers for Disease Control and Prevention (CDC) paint a disappointing picture of adult immunization against serious infectious diseases in the United States. In addition, a new consumer survey shows the vast majority of adult Americans lack awareness of vaccines and the severity of infectious diseases.

An expert panel discussed the data at a press conference held by the National Foundation for Infectious Diseases (NFID), which called for increased use of vaccines in adults to reduce needless illness and deaths associated with infectious diseases.

CDC's National Immunization Survey shows only 2.1 percent of adults 18 to 64 years of age are immunized against tetanus-diphtheria-whooping cough. Immunization to prevent shingles among people 60 and over was only 1.9 percent. Vaccine coverage for the prevention of HPV (human papillomavirus) among women 18 to 26 is about 10 percent. In addition, influenza and pneumococcal vaccination rates for the elderly are well below the 90 percent national target rates.

"Routine immunization of children in the United States has saved hundreds of thousands of lives and prevented millions of cases of disease, but vaccines are not just for children," said Anne Schuchat, MD, director of the CDC's National Center for Immunization and Respiratory Diseases. "These new data show there are not yet very many adults taking full advantage of the great advancements in prevention that have been made in the past few years."

"There are now 17 diseases that can be prevented from vaccines given to children, teens and adults. Several vaccines, including three fairly new ones licensed since 2005, are recommended specifically for the adult years. By skipping vaccination, people are leaving themselves needlessly vulnerable to significant illness, long-term suffering and even death," said Dr. Schuchat. "We are extremely fortunate in this country to have safe and effective vaccines available, but we have to use them better."

Immunization is recommended for U.S. adults to protect them against chickenpox, diphtheria, hepatitis A, hepatitis B, human papillomavirus/cervical cancer (HPV), influenza, measles, meningococcal disease, mumps, pertussis (whooping cough), pneumococcal disease, rubella, shingles and tetanus.

"Combined, these infectious diseases kill more Americans annually than either breast cancer, HIV/AIDS or traffic accidents," said William Schaffner, MD, Vice President of NFID and Chairman of the Department of Preventive Medicine at Vanderbilt University School of Medicine

"A concerted effort is needed to raise adult immunization rates," said Dr. Schaffner. "The important thing to remember is that deaths and illness associated with these infections are largely avoidable through vaccination."

National Survey Finds Low Awareness of Vaccines Among Adults

Also released today were results of a new national survey conducted by NFID that show most adults cannot name more than one or two diseases that are vaccine preventable in adults. Each vaccine for adults was identified by only 3 to 18 percent of those polled; the only exception was the influenza vaccine, which was named by just under half of respondents.

Also disconcerting is that half of those surveyed say they are not concerned about whether they or another adult family member gets a vaccine-preventable disease. When asked about specific diseases, consumers expressed most concern about getting influenza, which likely reflects the more frequent messages they receive about influenza versus the other diseases.

Low Immunization Rates Leaves Adults Vulnerable to Serious Illnesses

One adult vaccine with low immunization rates ( < 2 percent) prevents herpes zoster or shingles, a severely painful and debilitating infectious disease. "There are more than 1 million new cases of shingles in the U.S. every year; over half in people 60 and older," said Michael N. Oxman, MD, Professor, University of California, San Diego; Staff Physician at the San Diego VA Medical Center; and Chairman of the Shingles Prevention Study, the VA Cooperative Study that demonstrated the efficacy of the shingles vaccine. "The vaccine not only helps reduce the risk of getting shingles, but it reduces the incidence of postherpetic neuralgia (PHN), a long-lasting shingles pain syndrome that constitutes the most common serious and debilitating complication of shingles." PHN pain can last for years after the initial shingles outbreak and is often resistant to treatment.

Stanley A. Gall, MD, Professor of Obstetrics, Gynecology and Women's Health and the American College of Obstetricians and Gynecologists (ACOG) Liaison Member to the Advisory Committee on Immunization Practices, addressed the importance of using the HPV vaccine to protect women against human papillomavirus. "The 2007 reported coverage rate of 10 percent in women 18 to 26 is a start, but we need to get these rates up. This is a safe and effective vaccine that protects against cervical cancer. I urge all young women to talk to their doctors about getting the three-dose vaccine series."

Although immunization rates are higher for influenza than for other vaccines recommended for adults, "influenza remains a significant threat to the public health," according to Kristin L. Nichol, MD, MPH, MBA, Chief of Medicine, Minneapolis VA Medical Center and Professor of Medicine and Vice Chair, Department of Medicine, University of Minnesota. "We are learning more all the time about just how severe, debilitating and widespread influenza can be. A recent report connected influenza infection with an increased risk of heart attack and stroke. It is clear that our work is far from done."

Dr. Robert Hopkins, Associate Professor at the University of Arkansas for Medical Science and a member of the Adult Immunization Advisory Board of the American College of Physicians and the organization's Arkansas Chapter Governor, detailed the terrible burden of pneumococcal disease in adults. "Up to 5,000 Americans die every year from a disease that can be prevented by vaccination," said Dr. Hopkins. "Many pneumococcal infections can be prevented or their severity significantly reduced by this simple immunization."

The decades-long increase in pertussis (whooping cough) rates was highlighted by Dr. Mark Dworkin from the Division of Epidemiology and Biostatistics at the University of Illinois at Chicago School of Public Health. According to Dr. Dworkin, "we need to use the newly available booster vaccines against pertussis for adults and adolescents widely because this may get pertussis back under control. Adults and adolescents can get coughing illness that may last for weeks or even months and they represent a large reservoir of infection putting others, such as vulnerable infants, at increased risk of infection."

Dr. Schaffner called on everyone to focus more on this important issue for the public health good. "Low immunization rates represent a national public health crisis whose consequences affect the entire country as well as affected individuals and their families. The challenges to increasing rates are real, but the benefits of achieving high vaccination rates are substantial."

About the National Foundation for Infectious Diseases

The National Foundation for Infectious Diseases (NFID), a non-profit organization, has been a leading voice for education about infectious diseases and vaccination since 1973. It is dedicated to educating the public and healthcare professionals about the causes, treatment, and prevention of infectious diseases. For more information on vaccines and vaccine-preventable diseases, please visit http://www.nfid.org.

Contact:

Jennifer Corrigan Meredith Jarblum

Phone: 732-382-8898 Phone: 212-886-2226

Cell: 732-742-7148 Email: mjarblum@cooneywaters.com

Email: jenn.corrigan@comcast.net


'/>"/>
SOURCE National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
2. Study Reports Successful Cloning of Human Embryo Using Adult DNA
3. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. Research Identifies Need for Improved Understanding of Sickle Cell Disease in Adulthood
6. Genzyme Completes Enrollment in Pivotal, Phase 2 Clinical Trial of Clofarabine in Adult AML
7. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
8. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
9. Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year
10. Younger Adults Increasingly Treated for Heart Disease-related Conditions
11. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... April 21, 2017 , ... Providing for loved ones ... estate planning process, or where to even begin. “Now more than ever there are ... to properly protect yourself and your family,” said attorney Lisa Edgar Dickman, founder of ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... ... April 21, 2017 , ... Each year, everyone is ... day to clean, plant trees and look forward to a better future. However, supporting ... doing something outdoors. Indoor air quality can be two to five times more polluted ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal ... five common elements between the Obamacare program that most Republicans love to hate ... Warfarin poison to kill hogs. , Like Obamacare, the Miller program centers ...
(Date:4/21/2017)... ... April 21, 2017 , ... Indiana Fiber ... bandwidth upgrade infrastructure service to Tele-Media Solutions. IFN is delivering Multi-Gigabit data ... consortium member-owners, Tele-Media Solution’s protect transport with 3GB Dual Access Internet access now ...
Breaking Medicine News(10 mins):